TRB Chemedica Competitors and Similar CompaniesClear all
TRB Chemedica's competitors and similar companies include Repligen and Swedish Orphan Biovitrum.
 TRB Chemedica TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices. |  Repligen Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems. |  Swedish Orphan Biovitrum Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care. | |
Founding Date | Founding Date 1980 | Founding Date 1981 | Founding Date 2010 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Genève, CH HQ Buenos Aires, AR Biedermannsdorf, AT Campinas, BR Archamps, FR Feldkirchen, DE Sai Ying Pun, HK see more | Locations Waltham, US HQ Shanghai, CN Jüri, EE Castanet Tolosan, FR Ravensburg, DE Bengaluru, IN Waterford, IE see more | |
Employees | Employees 900 | Employees 1,78312% decrease | Employees 1,8401% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 7.7 b | Valuation ($) 11.1 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $634.4m (FY, 2024) | Revenue (est.) kr26b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $359.8m (FY, 2024) | Cost of goods kr5.8b (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $274.6m (FY, 2024) | Gross profit kr20.3b (FY, 2024) |
Net income | Net income N/A | Net income ($25.5m) (FY, 2024) | Net income kr3.9b (FY, 2024) |
Operating ⚠ | |||
Trademarks (US) | Trademarks (US) 2 (Jun, 2020) | Trademarks (US) 12 (FY, 2017) | Trademarks (US) N/A |
For sources of this data, please see the company profile
View Company Profiles
Repligen
HQ
Waltham, US
Employees
1,783↓ 12% decrease
Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems.
View companySwedish Orphan Biovitrum
HQ
Solna, SE
Employees
1,840↑ 1% increase
Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care.
View company